Your browser doesn't support javascript.
loading
Efficacy and tolerability of alirocumab in Austrian clinical practice - results of the non-interventional PEARL-AT study.
Leitner, Deborah R; Toplak, Hermann; Kedenko, Ludmilla; Steinmaurer, Thomas; Gräff, Verena; Metzner, Thomas; Schwaiger, Elisabeth M; Prager, Rudolf.
Affiliation
  • Leitner DR; Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University Graz, Graz, Austria.
  • Toplak H; Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University Graz, Graz, Austria.
  • Kedenko L; First Department of Internal Medicine, Paracelsus Medical University/Salzburger Landeskliniken, Salzburg, Austria.
  • Steinmaurer T; Department of Internal Medicine, Hospital Barmherzige Brüder Linz, Linz, Austria.
  • Gräff V; Landesklinik St. Veit im Pongau, St. Veit im Pongau, Austria.
  • Metzner T; Sanofi, Vienna, Austria.
  • Schwaiger EM; Sanofi, Vienna, Austria.
  • Prager R; Karl Landsteiner Society, Institute of Metabolic Diseases and Nephrology, Hietzing Hospital, Vienna, Austria.
Curr Med Res Opin ; 36(9): 1419-1425, 2020 09.
Article in En | MEDLINE | ID: mdl-32568565

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / PCSK9 Inhibitors / Hypercholesterolemia Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Curr Med Res Opin Year: 2020 Document type: Article Affiliation country: Austria Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / PCSK9 Inhibitors / Hypercholesterolemia Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Curr Med Res Opin Year: 2020 Document type: Article Affiliation country: Austria Country of publication: United kingdom